BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guerra Martinez C. P2X7 receptor in cardiovascular disease: The heart side. Clin Exp Pharmacol Physiol 2019;46:513-26. [PMID: 30834550 DOI: 10.1111/1440-1681.13079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Saber S, Youssef ME, Sharaf H, Amin NA, El-Shedody R, Aboutouk FH, El-Galeel YA, El-Hefnawy A, Shabaka D, Khalifa A, Saleh RA, Osama D, El-Zoghby G, Gobba NA. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats. Life Sci 2021;270:119123. [PMID: 33548287 DOI: 10.1016/j.lfs.2021.119123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zheng Q. Radioligands targeting purinergic P2X7 receptor. Bioorganic & Medicinal Chemistry Letters 2020;30:127169. [DOI: 10.1016/j.bmcl.2020.127169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Silvis MJM, Kaffka Genaamd Dengler SE, Odille CA, Mishra M, van der Kaaij NP, Doevendans PA, Sluijter JPG, de Kleijn DPV, de Jager SCA, Bosch L, van Hout GPJ. Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success. Front Immunol 2020;11:599511. [PMID: 33363540 DOI: 10.3389/fimmu.2020.599511] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Coccurello R, Volonté C. P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance. Front Endocrinol (Lausanne) 2020;11:199. [PMID: 32528404 DOI: 10.3389/fendo.2020.00199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li W, Jin D, Takai S, Hayakawa T, Ogata J, Yamanishi K, Yamanishi H, Okamura H. Impaired function of aorta and perivascular adipose tissue in IL-18-deficient mice. Am J Physiol Heart Circ Physiol 2019;317:H1142-56. [PMID: 31518161 DOI: 10.1152/ajpheart.00813.2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Andelova K, Egan Benova T, Szeiffova Bacova B, Sykora M, Prado NJ, Diez ER, Hlivak P, Tribulova N. Cardiac Connexin-43 Hemichannels and Pannexin1 Channels: Provocative Antiarrhythmic Targets. Int J Mol Sci 2020;22:E260. [PMID: 33383853 DOI: 10.3390/ijms22010260] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Tapia Cáceres F, Gaspari TA, Hossain MA, Samuel CS. Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors. IJMS 2022;23:7074. [DOI: 10.3390/ijms23137074] [Reference Citation Analysis]
8 Biswas A, Raza A, Das S, Kapoor M, Jayarajan R, Verma A, Shamsudheen KV, Murry B, Seth S, Bhargava B, Scaria V, Sivasubbu S, Rao VR. Loss of function mutation in the P2X7, a ligand-gated ion channel gene associated with hypertrophic cardiomyopathy. Purinergic Signal 2019;15:205-10. [PMID: 31152337 DOI: 10.1007/s11302-019-09660-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
9 Tassetto M, Scialdone A, Solini A, Di Virgilio F. The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy. Int J Mol Sci 2021;22:7110. [PMID: 34281162 DOI: 10.3390/ijms22137110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wang Z, Li L, Yang R, Xu X, Liang S. P2X receptors mediated abnormal interaction between satellite glial cells and neurons in visceral pathological changes. Cell Biol Int 2019;43:1346-52. [DOI: 10.1002/cbin.11195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 T Pournara D, Durner A, Kritsi E, Papakostas A, Zoumpoulakis P, Nicke A, Koufaki M. Design, Synthesis, and in vitro Evaluation of P2X7 Antagonists. ChemMedChem 2020;15:2530-43. [PMID: 32964578 DOI: 10.1002/cmdc.202000303] [Reference Citation Analysis]
12 Shokoples BG, Paradis P, Schiffrin EL. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2021;41:186-99. [PMID: 32998520 DOI: 10.1161/ATVBAHA.120.315116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Pegoraro A, De Marchi E, Adinolfi E. P2X7 Variants in Oncogenesis. Cells 2021;10:189. [PMID: 33477845 DOI: 10.3390/cells10010189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
14 Li M, Luo S, Zhang Y, Jia L, Yang C, Peng X, Zhao R. Production, characterization, and application of a monoclonal antibody specific for the extracellular domain of human P2X7R. Appl Microbiol Biotechnol 2020;104:2017-28. [PMID: 31930453 DOI: 10.1007/s00253-019-10340-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Nadeali Z, Rezaei FM, Aria H, Nikpour P. Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120482] [Reference Citation Analysis]
16 Yang Y, Zhang K, Huang S, Chen W, Mao H, Ouyang X, Chen L, Li L. Apelin‐13/APJ induces cardiomyocyte hypertrophy by activating the Pannexin‐1/P2X7 axis and FAM134B‐dependent reticulophagy. Journal Cellular Physiology. [DOI: 10.1002/jcp.30685] [Reference Citation Analysis]
17 Gil B, Smith J, Tang Y, Illes P, Engel T. Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor. Int J Mol Sci 2022;23:2380. [PMID: 35216493 DOI: 10.3390/ijms23042380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gratal P, Lamuedra A, Medina JP, Bermejo-Álvarez I, Largo R, Herrero-Beaumont G, Mediero A. Purinergic System Signaling in Metainflammation-Associated Osteoarthritis. Front Med (Lausanne) 2020;7:506. [PMID: 32984382 DOI: 10.3389/fmed.2020.00506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]